Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02129517 · ClinicalTrials.gov registry record · NA
Web-Based Tailored Educational Program in Improving Nurse Communication With Patients About Clinical Trials
A NA study, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 1,262
- Enrollment target
NCT02129517: Completed NA study, sponsored by Case Comprehensive Cancer Center.
NCT02129517 is a NA study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 1,262 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (10% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02129517, a NA study, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,262 participants
- Enrollment target
Study Summary
This pilot, randomized clinical trial studies a web-based tailored educational program in improving nurse communication with patients about clinical trial treatment options. A web-based tailored educational program may empower and prepare nurses to discuss clinical trial treatment options with patients and may also increase patient participation in clinical trials.
Primary Outcome
Behavioral intention will be assessed using 4 items (3 with 7 point scales, strongly agree/strongly disagree and 1 which asks for an estimated number of patients). An analysis of covariance (ANCOVA) will be used to compare intention scores, adjusting for the pre-intervention intention score as well as age, ethnicity, education, access to clinical trials, and years spent in nursing as well as other key factors found to be significantly imbalanced between groups.
Interventions
- OTHER survey administration
- OTHER IMPACT intervention
- OTHER Online education materials
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,262 participants |
| Start Date | 2014-11-07 |
| Est. Completion | 2017-10-01 |
| Phase | NA |
What the finished NCT02129517 record still lists
NCT02129517 is an interventional study that assigns participants to a tested intervention. Its 1,262 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (10% lower).
The record links to 0 conditions, and to 3 interventions - of which survey administration is the first listed.
NCT02129517 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02129517 about?
NCT02129517 is a clinical study titled "Web-Based Tailored Educational Program in Improving Nurse Communication With Patients About Clinical Trials". This pilot, randomized clinical trial studies a web-based tailored educational program in improving nurse communication with patients about clinical trial treatment options. A web-based tailored educational program may empower and prepare nurses to discuss clinical trial treatment options with patie...
What is the current status of trial NCT02129517?
This trial is currently completed. It is a NA study. The enrollment target is 1,262 participants. The study started on 2014-11-07. Estimated completion is 2017-10-01.
What interventions are being tested in trial NCT02129517?
The interventions under investigation include: survey administration (OTHER), IMPACT intervention (OTHER), Online education materials (OTHER).
Who is sponsoring clinical trial NCT02129517?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02129517's enrollment target sits among peer trials
1,262 79th of 2000 higher than 1,922 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06119581 · 1,264 participants · Phase 3
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- NCT06712316 · 1,260 participants · Phase 2
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
- NCT06812273 · 1,260 participants · NA
Mediators and Moderators of Auditory Training
- NCT06931340 · 1,260 participants · Phase 3
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI